ReviewGut and liver2026
Biliary Stent Placement by Endoscopic Retrograde Cholangiopancreatography: Quality Indicators and Technical Applications.
Review in Gut and liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) has become a pivotal therapeutic option for the management of various biliary disorders. ERCP is an intrinsically complex procedure associated with risks of adverse events, including pancreatitis, bleeding, and perforation; thus, experienced endoscopists must maintain adequate procedural competence. Therefore, endoscopic societies have established quality indicators to ensure procedural safety and clinical outcomes. Furthermore, achieving optimal technical outcomes in biliary stent placement requires a thorough understanding of the appropriate selection and the characteristics of different biliary stents for each clinical situation. Although the most common indication for ERCP is common bile duct stone removal in the setting of acute cholangitis, benign and malignant biliary strictures remain a major focus of clinical research. In this context, this review summarizes the current quality benchmarks proposed by major endoscopic societies and provides an overview of mechanical properties of plastic stents and self-expandable metal stents and their technical considerations in pancreatobiliary disorders that are frequently encountered in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.